© Globe Newswire
13.09.2024
FAGR
LISTED
EURONEXT
Fagron completes share buy-back program
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 September 2024 – 6PM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.09.2024
ZEAL
LISTED
CPH
Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th
News Preview
Press Release – No. 9 / 2024...
Themefolio
Profiler
Peergroup
© PR Newswire
13.09.2024
MOB
LISTED
STO
Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients
News Preview
STOCKHOLM, Sept. 13, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces that the company has received information about clinical cure in a subset of patients in the ongoing North American Phase 3 study for MOB-015 against nail fungus. The number of patients who have achieved clinical cure in this blinded subset of patients is lower than t...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
13.09.2024
CHEMM
LISTED
CPH
Notification of managers’ transactions
News Preview
ANNOUNCEMENT NO. 274...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
12.09.2024
IMCR
LISTED
NASDAQ
Immunocore to present at the 2024 Cantor Global Healthcare Conference
News Preview
Immunocore to present at the 2024 Cantor Global Healthcare Conference...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
CU6
LISTED
ASX
SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort
News Preview
Highlights
Cohort 4 of the SECuRE trial is the first to assess multiple cycles of 67Cu-SAR-bisPSMA at the highest dose of 12GBq.The Safety Review Committee (SRC) assessed early data from the first 3 participants in cohort 4 who received 2 doses of 67Cu-SAR-bisPSMA. Two of these participants had completed the dose limiting toxicity (DLT) period an...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
ZEAL
LISTED
CPH
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
News Preview
Company announcement – No. 45 / 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
TEM
LISTED
NASDAQ
Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
News Preview
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the beta launch of a patient-facing app, olivia, an AI-enabled personal health concierge to empower individuals to holistically organize, manage, and proactively take control of their own health data. olivi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
SOBI
LISTED
STO
Sobi® and Enable Injections announce agreement to develop and distribute Aspaveli® in combination with enFuse® in Sobi territories
News Preview
STOCKHOLM, Sept. 12, 2024 /PRNewswire/ -- Sobi® (STO: SOBI) and Enable Injections, Inc. (Enable) today announced an international development and distribution agreement across Sobi territories for the enFuse® Injector, for the subcutaneous delivery of Aspaveli® (pegcetacoplan).
The enFuse Injector, to be produced by Enable and distributed by So...
Themefolio
Profiler
Peergroup
© PR Newswire
12.09.2024
AFX
LISTED
XETR
ZEISS Redefines Disease Management and Treatment within the ZEISS Retina Workflow
News Preview
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:
THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
ICLR
LISTED
NASDAQ
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced results from a recent survey of over 100 professionals engaged in oncology drug development to understand the current state of emerging oncology treatment development, including the associated clinical trial dynamics. Respond...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.09.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
12.09.2024
BAVA
LISTED
CPH
Bavarian Nordic Provides Update on the Mpox Vaccine Supply Situation
News Preview
COPENHAGEN, Denmark, September 12, 2024 – Bavarian Nordic A/S (OMX: BAVA), the vaccine manufacturer of MVA-BN®, the only approved non-replicating smallpox and mpox vaccine (marketed as JYNNEOS®, IMVAMUNE® and IMVANEX®) today provided an update of its supply and manufacturing activities in support of the ongoing mpox outbreak....
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ASND
LISTED
NASDAQ
Ascendis Pharma Receives Orphan Drug Exclusivity in the U.S. for YORVIPATH® (Palopegteriparatide) for the Treatment of Hypoparathyroidism in Adults
News Preview
– U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for YORVIPATH in the United States for the treatment of hypoparathyroidism in adults...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
CHEMM
LISTED
CPH
Guidance for the 2024/25 financial year
News Preview
ANNOUNCEMENT NO. 272...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ORY
LISTED
BME
ORYZON Receives “Intention to Grant” Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder
News Preview
From the European Patent Office From the European Patent Office...
Themefolio
Profiler
Peergroup
© PR Newswire
11.09.2024
GETI B
LISTED
STO
Getinge completes the acquisition of Paragonix Technologies
News Preview
Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc.
GOTHENBURG, Sweden, Sept. 11, 2024 /PRNewswire/ -- On August 22, 2024, Getinge announced that it had entered into an agreement to acquire Paragonix Technologies, Inc., a leading U.S. company in organ transport products and servic...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
NSIS B
LISTED
CPH
Trading by management and close relations of management
News Preview
Please read the full announcement in PDF...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
ORNBV
LISTED
HEL
Inside information: Orion upgrades full-year outlook for 2024
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION11 SEPTEMBER 2024 at 09:30 EEST...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
IBAB
LISTED
EURONEXT
IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
News Preview
Louvain-la-Neuve, Belgium, September 11, 2024 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, is pleased to share the below press release from its joint venture PanTera, which is focussed on the production of actinium-225, a novel radioisotope used in a new class of targeted treatments for cancer....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
GMAB
LISTED
CPH
Capital Increase in Genmab as a Result of Employee Warrant Exercise
News Preview
Company Announcement...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
SN
LISTED
LSE
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
News Preview
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help plan and perform total ankle replacement (TAR) procedures. Engineered using 3D Systems’ VSP® surgical planning workflows, all-in-one TOTAL ANKLE Pati...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2024
MURA
LISTED
NASDAQ
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
News Preview
Company will provide clinical overview and update on late-stage clinical candidate, nemvaleukin alfa, and overview of IL-18 pipeline program...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2024
DFTX
LISTED
NASDAQ
MindMed Announces New Employee Inducement Grants
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 70,000 common shar...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2024
ZEAL
LISTED
CPH
Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide
News Preview
Company announcement – No. 44 / 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
FAGR
LISTED
EURONEXT
Fagron’s share buy-back program: Weekly update
News Preview
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
News Preview
COPENHAGEN, Denmark, September 6, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.09.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2024
AMRX
LISTED
NASDAQ
Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration
News Preview
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) and Shilpa Medicare Limited (“Shilpa”) announced U.S. Food and Drug Administration (FDA) approval of BORUZU™, a new presentation of bortezomib for ready-to-use subcutaneous administration or intravenous (IV) administration. This new ready-to-use oncology product reduces the co...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
BAVA
LISTED
CPH
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
POAI
LISTED
NASDAQ
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
News Preview
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled to deliver a virtual presentation and host investor one-on-one meetings at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th through 11th in New York...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
HNSA
LISTED
STO
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
News Preview
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ -- Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, September 11 at 8:00 AM EST. Mr. Tsao's research focuses on biopharmaceuticals and specialty pharmaceuticals. Th...
Themefolio
Profiler
Peergroup
© PR Newswire
05.09.2024
HNSA
LISTED
STO
Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference
News Preview
LUND, Sweden, Sept. 5, 2024 /PRNewswire/ -- Hansa Biopharma today announced that Søren Tulstrup will participate in a Fireside chat hosted by Douglas Tsao, Managing Director and Senior Financial Analyst at H.C. Wainwright on Wednesday, September 11 at 8:00 AM EST. Mr. Tsao's research focuses on biopharmaceuticals and specialty pharmaceuticals. Th...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
BAVA
LISTED
CPH
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the first doses of its mpox vaccine, MVA-BN®, also known as JYNNEOS®, has arrived today in the Democratic Republic of Congo (DRC). Additional shipments to the DRC are planned within the next week adding to a total of more than 250,000 vaccines donated by t...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
NSIS B
LISTED
CPH
Major shareholder announcement
News Preview
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and share capital through financial instruments....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
BAVA
LISTED
CPH
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
News Preview
COPENHAGEN, Denmark, September 5, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 7,164,460 as a consequence of employees’ exercise of warrants....
Themefolio
Profiler
Peergroup
© BusinessWire
05.09.2024
GNS
LISTED
LSE
Genus plc Preliminary Results for the Year Ended 30 June 2024
News Preview
Genus (LSE:GNS), a leading global animal genetics company, today announces its preliminary results for the year ended 30 June 2024. The full report has been made available on the investors section of the Genus plc website. The Company will discuss its corporate, operational and financial highlights in a pre-recorded webcast at 7:01 AM GMT, 2.01 ES...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.09.2024
GN
LISTED
CPH
Trading in GN Store Nord shares by board members, executives and associated persons
News Preview
Trading in GN Store Nord shares by board members, executives and associated persons...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2024
1SXP
LISTED
XETR
Listed on the MDAX for the first time
News Preview
Promotion for SCHOTT Pharma: Listed on the MDAX for the first time
SCHOTT Pharma to join the 90 most important shares listed on the Frankfurt stock exchange as of September 23, 2024
MDAX promotion proves confidence in the company’s business model, strategic focus and ideal market position
The shares of SCHOTT Pharma AG & Co. KGaA, a global......
Themefolio
Profiler
Peergroup
© EQS Newswire
05.09.2024
1SXP
LISTED
XETR
Erstmalige Aufnahme in den MDAX
News Preview
Aufstieg für SCHOTT Pharma: Erstmalige Aufnahme in den MDAX
SCHOTT Pharma gehört ab dem 23. September 2024 zu den 90 wichtigsten Aktien an der Frankfurter Wertpapierbörse
MDAX-Aufstieg belegt Vertrauen in das Geschäftsmodell, die strategische Ausrichtung und die optimale Marktposition des Unternehmens
Die Aktien der SCHOTT Pharma AG & Co. KGa......
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2024
QGEN
LISTED
NYSE
QIAGEN und Lilly kooperieren bei der Entwicklung eines QIAstat-Dx IVD-Panels zur Identifizierung von Patienten mit erhöhtem Risiko für Alzheimererkrankungen
News Preview
QIAGEN entwickelt erstes QIAstat-Dx IVD-Panel für neurodegenerative Anwendungen // Neues QIAstat-Dx-Panel identifiziert APOE-Genotypen, die als einer von vielen Faktoren eine Rolle bei der Einschätzung des Risikos einer Alzheimererkrankung spielen können // Kooperation sieht Markteinführung des ersten kommerziell erhältlichen IVD-Kits für die APOE-...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
TEM
LISTED
NASDAQ
Tempus Announces Real World Data Collaboration with BioNTech
News Preview
Tempus AI, Inc. (NASDAQ: TEM, “Tempus”), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE (Nasdaq: BNTX, “BioNTech”), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collab...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
HELP
LISTED
NASDAQ
Cybin to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
News Preview
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will participate in a firesid...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2024
DFTX
LISTED
NASDAQ
MindMed to Participate in September Investor Conferences
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will participate in the following investor conferences:
H.C. Wainwright 26th Annual Global Investm...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
INDV
LISTED
NASDAQ
Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).
Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option SLOUGH...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
INDV
LISTED
NASDAQ
Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
News Preview
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS IT FORMS PART OF DOMESTIC LAW IN THE UK BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018).
Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option SLOUGH...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ASND
LISTED
NASDAQ
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
News Preview
Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the YORVIPATH® U.S. commercial launch, and general corporate purposes Proceeds to support continued development and commercialization of Endocrine Rare Disease products, including the YORVIPATH® U.S. commercial launch, and general corporate...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
QGEN
LISTED
NYSE
QIAGEN N.V. announces conversion price of new net share settled convertible bonds
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
ASND
LISTED
NASDAQ
Ascendis Pharma Reports Second Quarter 2024 Financial Results
News Preview
COPENHAGEN, Denmark, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results for the second quarter ended June 30, 2024, and provided a business update....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
OSE
LISTED
EURONEXT
Informations relatives au nombre total de droits de vote et d’actions composant le capital
News Preview
Informations relatives au nombre total de droits de vote et d’actions composant le capital...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
QGEN
LISTED
NYSE
QIAGEN N.V. announces successful placement of new net share settled convertible bonds
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. NOT FOR DISTRIBUTION TO ANY U.S. PERSON. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
CALTX
LISTED
STO
Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- The shareholders of Calliditas Therapeutics AB (publ) ("Calliditas Therapeutics"), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the extraordinary general meeting on Monday 30 September 2024 at 12:00 p.m. CEST at Advokatfirman Vinge's premises on Smålandsgatan 20, SE-111 46, St...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
CALTX
LISTED
STO
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- Following the announcement by Asahi Kasei Corporation ("Asahi Kasei") on September 2, 2024 that it controls more than 90 percent of the outstanding shares of Calliditas Therapeutics AB (Nasdaq: CALT) ("Calliditas" or the "Company"), and declared its offers to purchase all of the outstanding Common Shares a...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
CALTX
LISTED
STO
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- Following the announcement by Asahi Kasei Corporation ("Asahi Kasei") on September 2, 2024 that it controls more than 90 percent of the outstanding shares of Calliditas Therapeutics AB (Nasdaq: CALT) ("Calliditas" or the "Company"), and declared its offers to purchase all of the outstanding Common Shares a...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2024
ICLR
LISTED
NASDAQ
ICON plc to Present at the Baird 2024 Global Healthcare Conference
News Preview
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Baird 2024 Global Healthcare Conference on Tuesday, September 10, 2024 at 3:45 pm ET.
Any changes to this event and links to the live webcast will be posted on the Invest...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ORX
LISTED
STO
Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024
News Preview
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm, Sweden.
On the day, between 2:25-2:45 CET (room Event Smal...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
ORX
LISTED
STO
Orexo to participate in Pareto Securities´ 15th Annual Healthcare Conference 2024
News Preview
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ -- Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities' 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm, Sweden.
On the day, between 2:25-2:45 CET (room Event Smal...
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
RAY B
LISTED
STO
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
News Preview
STOCKHOLM, Sept. 3, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has treated its first patient using RaySearch's oncology information system RayCare®* together with a Varian TrueBeam®** linear accelerator. The treatment was successfully carried out on September 2, 2024.
Since its es...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2024
GN
LISTED
CPH
Trading in GN Store Nord shares by board members, executives and associated persons
News Preview
GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them....
Themefolio
Profiler
Peergroup
© EQS Newswire
03.09.2024
EVT
LISTED
XETR
Evotec gibt Veränderung im Vorstand bekannt
News Preview
Dr. Matthias Evers tritt mit Wirkung zum 01. Oktober 2024 als Chief Business Officer zurück
Verantwortlichkeiten werden auf andere Vorstandsressorts verteilt
Hamburg, 03. September 2024:
Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief Business Officer......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
